Calian Group Ltd. (TSE:CGY – Get Free Report) insider Patrick Belanger Houston sold 6,432 shares of the company’s stock in a transaction that occurred on Wednesday, May 20th. The shares were sold at an average price of C$80.91, for a total value of C$520,413.12. Following the sale, the insider directly owned 22,266 shares of the company’s stock, valued at approximately C$1,801,542.06. This represents a 22.41% decrease in their ownership of the stock.
Calian Group Stock Up 2.0%
Shares of Calian Group stock opened at C$86.56 on Wednesday. The company has a market cap of C$987.74 million, a P/E ratio of 30.37, a PEG ratio of 2.50 and a beta of 0.92. The company has a debt-to-equity ratio of 63.54, a quick ratio of 1.20 and a current ratio of 1.51. Calian Group Ltd. has a one year low of C$37.70 and a one year high of C$86.59. The firm has a fifty day moving average of C$74.37 and a two-hundred day moving average of C$66.57.
Calian Group (TSE:CGY – Get Free Report) last announced its quarterly earnings data on Thursday, May 14th. The company reported C$1.30 EPS for the quarter. The company had revenue of C$228.70 million during the quarter. Calian Group had a net margin of 3.97% and a return on equity of 10.35%. On average, analysts forecast that Calian Group Ltd. will post 4.9475219 earnings per share for the current year.
Calian Group Announces Dividend
Analyst Upgrades and Downgrades
CGY has been the subject of a number of analyst reports. Canaccord Genuity Group increased their target price on Calian Group from C$63.00 to C$80.00 in a research note on Friday, February 13th. Ventum Financial increased their target price on Calian Group from C$84.00 to C$94.00 and gave the stock a “buy” rating in a research note on Tuesday, March 10th. Canadian Imperial Bank of Commerce increased their target price on Calian Group from C$76.00 to C$90.00 in a research note on Friday, May 15th. Acumen Capital increased their target price on Calian Group from C$70.00 to C$85.00 and gave the stock a “buy” rating in a research note on Friday, February 13th. Finally, ATB Cormark Capital Markets increased their target price on Calian Group from C$92.50 to C$98.50 and gave the stock an “outperform” rating in a research note on Tuesday, May 19th. Eight research analysts have rated the stock with a Buy rating, Based on data from MarketBeat, the company currently has an average rating of “Buy” and a consensus target price of C$87.94.
Check Out Our Latest Analysis on CGY
About Calian Group
Calian Group Ltd operates through four segments namely Advanced Technologies, Health, Learning, and Information Technology. It generates maximum revenue from the Health segment. The company serves health, defence, security, aerospace, engineering, AgTech, and IT industries. Its Health segment includes Clinical Services; Nursing Services; Psychological Services and Medical Property Management. The Advanced Technologies segment includes Engineering Solutions and Services; Nuclear and Environmental Services; Satcom; DOCSIS; Electronics Design and Manufacturing and Agricultural Technology.
Featured Articles
- Five stocks we like better than Calian Group
- Banks Are Buying Back Stock Hand Over Fist, Including These 3 Names
- 2 Aluminum Stocks Poised for Big Tariff-Related Gains
- AutoZone’s Pullback Sets Up a Long-Term Buying Opportunity
- AST SpaceMobile’s June Launch Plan Puts Its 2026 Satellite Goal Back in Focus
Receive News & Ratings for Calian Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Calian Group and related companies with MarketBeat.com's FREE daily email newsletter.
